Please login to the form below

Not currently logged in
Email:
Password:

Philips promotes Simon McGuire to health systems lead

He was previously GM at Philips Respironics Respiratory Drug Delivery

Simon McGuireTechnology company Philips has appointed Simon McGuire as its health systems lead for the UK and Ireland, reporting directly to chief executive officer Neil Mesher.

His new role at the company will see him lead and expand the health systems business to “further strengthen Philips’ position within the healthcare market”.

Mesher said: “I am delighted that Simon will be heading up the Health Systems organisation.

“Following his track record of success in driving business growth within the respiratory drug delivery business I am confident that he will take the health systems organisation to the next level.”

McGuire was previously Philips' general manager of respiratory drug delivery in sleep and respiratory care, having joined the drug in 2008.

He said: “I look forward to leading the UKI team as we work together to deliver innovative and integrated services and solutions which break down the boundaries that stand in the way of more patient-centric care.”

1st December 2017

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Just::Health Communications

Just:: is a different kind of healthcare communications agency. Since 2006, we’ve been collaborating with clients around the world to...

Latest intelligence

OUTiCO win Best in UK Pharmaceutical Outsourcing award
The Corporate LiveWire Healthcare and Life Sciences Awards celebrate global companies and individuals who have excelled over the past 12 months....
artificial-intelligence-in-healthcare.jpg
Artificial Intelligence in Healthcare
Artificial intelligence is already out-diagnosing experts, but would you put a computer in charge of your healthcare? The good, the bad; we take a look....
World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer
Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...

Infographics